nodes	percent_of_prediction	percent_of_DWPC	metapath
Trisalicylate-choline—PTGS2—Barrett's esophagus	0.856	1	CbGaD
Trisalicylate-choline—Epigastric pain—Omeprazole—Barrett's esophagus	0.00679	0.0625	CcSEcCtD
Trisalicylate-choline—Epigastric pain—Esomeprazole—Barrett's esophagus	0.00679	0.0625	CcSEcCtD
Trisalicylate-choline—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—Barrett's esophagus	0.0053	0.173	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—Barrett's esophagus	0.00421	0.138	CbGpPWpGaD
Trisalicylate-choline—Hypocalcaemia—Omeprazole—Barrett's esophagus	0.00359	0.033	CcSEcCtD
Trisalicylate-choline—Hypocalcaemia—Esomeprazole—Barrett's esophagus	0.00359	0.033	CcSEcCtD
Trisalicylate-choline—PTGS1—Eicosanoid Synthesis—PTGES—Barrett's esophagus	0.00345	0.113	CbGpPWpGaD
Trisalicylate-choline—Injection site reaction—Esomeprazole—Barrett's esophagus	0.00326	0.03	CcSEcCtD
Trisalicylate-choline—Injection site reaction—Omeprazole—Barrett's esophagus	0.00326	0.03	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Omeprazole—Barrett's esophagus	0.003	0.0276	CcSEcCtD
Trisalicylate-choline—Oesophagitis—Esomeprazole—Barrett's esophagus	0.003	0.0276	CcSEcCtD
Trisalicylate-choline—Lightheadedness—Omeprazole—Barrett's esophagus	0.00294	0.027	CcSEcCtD
Trisalicylate-choline—Lightheadedness—Esomeprazole—Barrett's esophagus	0.00294	0.027	CcSEcCtD
Trisalicylate-choline—PTGS2—Eicosanoid Synthesis—PTGES—Barrett's esophagus	0.00274	0.0894	CbGpPWpGaD
Trisalicylate-choline—Magnesium salicylate—PTGS2—Barrett's esophagus	0.00241	0.541	CrCbGaD
Trisalicylate-choline—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.00218	0.02	CcSEcCtD
Trisalicylate-choline—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.00218	0.02	CcSEcCtD
Trisalicylate-choline—Asthma—Esomeprazole—Barrett's esophagus	0.00206	0.0189	CcSEcCtD
Trisalicylate-choline—Asthma—Omeprazole—Barrett's esophagus	0.00206	0.0189	CcSEcCtD
Trisalicylate-choline—Salsalate—PTGS2—Barrett's esophagus	0.00205	0.46	CrCbGaD
Trisalicylate-choline—PTGS1—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00192	0.0626	CbGpPWpGaD
Trisalicylate-choline—Weight increased—Omeprazole—Barrett's esophagus	0.00187	0.0172	CcSEcCtD
Trisalicylate-choline—Weight increased—Esomeprazole—Barrett's esophagus	0.00187	0.0172	CcSEcCtD
Trisalicylate-choline—Epistaxis—Omeprazole—Barrett's esophagus	0.00173	0.0159	CcSEcCtD
Trisalicylate-choline—Epistaxis—Esomeprazole—Barrett's esophagus	0.00173	0.0159	CcSEcCtD
Trisalicylate-choline—Hepatitis—Omeprazole—Barrett's esophagus	0.00165	0.0152	CcSEcCtD
Trisalicylate-choline—Hepatitis—Esomeprazole—Barrett's esophagus	0.00165	0.0152	CcSEcCtD
Trisalicylate-choline—Hallucination—Omeprazole—Barrett's esophagus	0.00164	0.0151	CcSEcCtD
Trisalicylate-choline—Hallucination—Esomeprazole—Barrett's esophagus	0.00164	0.0151	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.00156	0.0143	CcSEcCtD
Trisalicylate-choline—Erythema multiforme—Omeprazole—Barrett's esophagus	0.00156	0.0143	CcSEcCtD
Trisalicylate-choline—Tinnitus—Esomeprazole—Barrett's esophagus	0.00154	0.0141	CcSEcCtD
Trisalicylate-choline—Tinnitus—Omeprazole—Barrett's esophagus	0.00154	0.0141	CcSEcCtD
Trisalicylate-choline—Flushing—Omeprazole—Barrett's esophagus	0.00153	0.0141	CcSEcCtD
Trisalicylate-choline—Flushing—Esomeprazole—Barrett's esophagus	0.00153	0.0141	CcSEcCtD
Trisalicylate-choline—PTGS2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00152	0.0497	CbGpPWpGaD
Trisalicylate-choline—Dysgeusia—Esomeprazole—Barrett's esophagus	0.00141	0.0129	CcSEcCtD
Trisalicylate-choline—Dysgeusia—Omeprazole—Barrett's esophagus	0.00141	0.0129	CcSEcCtD
Trisalicylate-choline—Confusional state—Omeprazole—Barrett's esophagus	0.00118	0.0109	CcSEcCtD
Trisalicylate-choline—Confusional state—Esomeprazole—Barrett's esophagus	0.00118	0.0109	CcSEcCtD
Trisalicylate-choline—Shock—Esomeprazole—Barrett's esophagus	0.00115	0.0106	CcSEcCtD
Trisalicylate-choline—Shock—Omeprazole—Barrett's esophagus	0.00115	0.0106	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.00113	0.0104	CcSEcCtD
Trisalicylate-choline—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.00113	0.0104	CcSEcCtD
Trisalicylate-choline—Anorexia—Esomeprazole—Barrett's esophagus	0.00112	0.0103	CcSEcCtD
Trisalicylate-choline—Anorexia—Omeprazole—Barrett's esophagus	0.00112	0.0103	CcSEcCtD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—SLC9A1—Barrett's esophagus	0.0011	0.0361	CbGpPWpGaD
Trisalicylate-choline—Somnolence—Omeprazole—Barrett's esophagus	0.00104	0.00958	CcSEcCtD
Trisalicylate-choline—Somnolence—Esomeprazole—Barrett's esophagus	0.00104	0.00958	CcSEcCtD
Trisalicylate-choline—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—Barrett's esophagus	0.00104	0.034	CbGpPWpGaD
Trisalicylate-choline—Dyspepsia—Omeprazole—Barrett's esophagus	0.00103	0.00948	CcSEcCtD
Trisalicylate-choline—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00103	0.00948	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Esomeprazole—Barrett's esophagus	0.00102	0.00936	CcSEcCtD
Trisalicylate-choline—Decreased appetite—Omeprazole—Barrett's esophagus	0.00102	0.00936	CcSEcCtD
Trisalicylate-choline—PTGS1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00102	0.0333	CbGpPWpGaD
Trisalicylate-choline—Pain—Omeprazole—Barrett's esophagus	0.001	0.00921	CcSEcCtD
Trisalicylate-choline—Constipation—Esomeprazole—Barrett's esophagus	0.001	0.00921	CcSEcCtD
Trisalicylate-choline—Pain—Esomeprazole—Barrett's esophagus	0.001	0.00921	CcSEcCtD
Trisalicylate-choline—Constipation—Omeprazole—Barrett's esophagus	0.001	0.00921	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000965	0.00888	CcSEcCtD
Trisalicylate-choline—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000965	0.00888	CcSEcCtD
Trisalicylate-choline—Urticaria—Esomeprazole—Barrett's esophagus	0.00093	0.00856	CcSEcCtD
Trisalicylate-choline—Urticaria—Omeprazole—Barrett's esophagus	0.00093	0.00856	CcSEcCtD
Trisalicylate-choline—Pruritus—Omeprazole—Barrett's esophagus	0.000829	0.00762	CcSEcCtD
Trisalicylate-choline—Pruritus—Esomeprazole—Barrett's esophagus	0.000829	0.00762	CcSEcCtD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—PTGS2—Barrett's esophagus	0.000815	0.0266	CbGpPWpGaD
Trisalicylate-choline—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000801	0.00737	CcSEcCtD
Trisalicylate-choline—Diarrhoea—Omeprazole—Barrett's esophagus	0.000801	0.00737	CcSEcCtD
Trisalicylate-choline—PTGS1—Overview of nanoparticle effects—CXCL8—Barrett's esophagus	0.00079	0.0258	CbGpPWpGaD
Trisalicylate-choline—Dizziness—Omeprazole—Barrett's esophagus	0.000774	0.00712	CcSEcCtD
Trisalicylate-choline—Dizziness—Esomeprazole—Barrett's esophagus	0.000774	0.00712	CcSEcCtD
Trisalicylate-choline—Vomiting—Omeprazole—Barrett's esophagus	0.000745	0.00685	CcSEcCtD
Trisalicylate-choline—Vomiting—Esomeprazole—Barrett's esophagus	0.000745	0.00685	CcSEcCtD
Trisalicylate-choline—Rash—Esomeprazole—Barrett's esophagus	0.000738	0.00679	CcSEcCtD
Trisalicylate-choline—Rash—Omeprazole—Barrett's esophagus	0.000738	0.00679	CcSEcCtD
Trisalicylate-choline—Dermatitis—Omeprazole—Barrett's esophagus	0.000738	0.00679	CcSEcCtD
Trisalicylate-choline—Dermatitis—Esomeprazole—Barrett's esophagus	0.000738	0.00679	CcSEcCtD
Trisalicylate-choline—Headache—Esomeprazole—Barrett's esophagus	0.000734	0.00675	CcSEcCtD
Trisalicylate-choline—Headache—Omeprazole—Barrett's esophagus	0.000734	0.00675	CcSEcCtD
Trisalicylate-choline—Nausea—Esomeprazole—Barrett's esophagus	0.000696	0.0064	CcSEcCtD
Trisalicylate-choline—Nausea—Omeprazole—Barrett's esophagus	0.000696	0.0064	CcSEcCtD
Trisalicylate-choline—PTGS1—Eicosanoid Synthesis—PTGS2—Barrett's esophagus	0.000676	0.0221	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Overview of nanoparticle effects—CXCL8—Barrett's esophagus	0.000627	0.0205	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Barrett's esophagus	0.000565	0.0185	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Biological oxidations—CYP26A1—Barrett's esophagus	0.00054	0.0177	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—Barrett's esophagus	0.000379	0.0124	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000376	0.0123	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000328	0.0107	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Barrett's esophagus	0.000289	0.00946	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000274	0.00895	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000246	0.00805	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.000239	0.00782	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—Barrett's esophagus	0.000236	0.00772	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000217	0.00711	CbGpPWpGaD
Trisalicylate-choline—PTGS2—C-MYB transcription factor network—CDKN2A—Barrett's esophagus	0.000211	0.00689	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000195	0.00639	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—CXCL8—Barrett's esophagus	0.000146	0.00476	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000134	0.0044	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PTGES—Barrett's esophagus	0.000122	0.00399	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PTGES—Barrett's esophagus	9.68e-05	0.00316	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—CYP26A1—Barrett's esophagus	9.24e-05	0.00302	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Spinal Cord Injury—TP53—Barrett's esophagus	8.93e-05	0.00292	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—CYP26A1—Barrett's esophagus	7.33e-05	0.0024	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	6.83e-05	0.00223	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—SLC9A1—Barrett's esophagus	6.66e-05	0.00218	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—SLC9A1—Barrett's esophagus	6.31e-05	0.00206	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	6.08e-05	0.00199	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	5.42e-05	0.00177	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	5.37e-05	0.00176	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—SLC9A1—Barrett's esophagus	5.29e-05	0.00173	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PPARG—Barrett's esophagus	3.04e-05	0.000994	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Disease—APC—Barrett's esophagus	2.99e-05	0.000976	CbGpPWpGaD
Trisalicylate-choline—PTGS2—Metabolism—PPARG—Barrett's esophagus	2.41e-05	0.000789	CbGpPWpGaD
Trisalicylate-choline—PTGS1—Metabolism—PTGS2—Barrett's esophagus	2.39e-05	0.000782	CbGpPWpGaD
